US's FluMist can now be administered by a healthcare provider or by recipient or caregiver aged 18 or above. India's Nasovac S4 faces hurdles like cost, availability & low acceptance.
Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.
The Union health ministry said that those who have previously taken Covishield and Covaxin could take the nasal vaccine as a heterologous booster dose.
Nitric oxide used in nasal spray prevents SARS-CoV-2 from spreading to the lungs and can stop replication of the virus, finds study by researchers affiliated with makers of FabiSpray.
Nasal vaccines and sprays have been subject of discussion since early days of Covid, with research finally making headway into actually testing them for mucosal immunity.
The development of mucosal vaccines for Covid has been spurred on by the success of the oral polio vaccine, which induces 'mucosal immunity' in the gut.
Clean energy is “no longer the sideshow, it is the show”, BVR Subrahmanyam told the Odisha summit, warning India to lead the global shift or risk others’ tech dominance.
Dubai airshow crash & pilot death have rekindled concerns over pilot safety, and need for smarter automated systems that can step in when G-forces, temporary loss of consciousness hit the pilot.
None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.
COMMENTS